
Quarterly Result30 Jan 2026, 08:22 pm
Aster DM Healthcare Delivers Steady Q3 FY26 Performance; Revenues Up by 13% YoY to INR 1,186 Crs
AI Summary
Aster DM Healthcare has announced its financial results for the quarter ended December 31, 2025, reporting a 13% YoY increase in revenue to INR 1,186 Crs. The company's operating EBITDA grew by 17% YoY to INR 237 Crs, with operating EBITDA margins standing at 20.2%. The combined performance of Aster and Quality Care India Ltd (QCIL) showed a 15% YoY increase in revenue to INR 2,366 Crs and a 22% YoY increase in operating EBITDA to INR 503 Crs. The merger between Aster and QCIL is expected to be completed by Q1 FY27, subject to regulatory and compliance requirements.
Key Highlights
- Revenue for Q3 FY26 grew 13% YoY to INR 1,186 Crs
- Operating EBITDA (ex-Kasaragod) grew 17% YoY to INR 237 Crs in Q3 FY26
- Operating EBITDA Margins (ex-Kasaragod) stood at 20.2% in Q3 FY26
- Aster + QCIL (Combined Proforma) delivers strong performance; Q3 FY26 Revenues up by 15% to INR 2,366 Crs
- Merger between Aster and QCIL expected to be completed by Q1 FY27